Alternatives to Molecular Glue Labs

Computational platform using LLMs trained on biological and chemical data for drug discovery.

Genocure AI is developing AI-powered solutions for oncology drug discovery and development.

AI-powered antibody discovery platform.

BioCorteX is a tech bio company developing precision medicine solutions using AI-powered in-silico simulations to understand drug-bacteria interactions and personalize treatments.

AI-powered drug discovery platform for accelerated molecular design.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

A vertically-integrated procurement platform for the life sciences industry.

A global leader in clinical pharmacology and bioanalytical sciences.

Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.

Automated wet lab for AI-driven protein design, enabling rapid synthesis, expression, and testing of thousands of protein designs.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

Pioneering vision restoration therapies for severe retinal degenerations.

A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.

Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.

Platform designed to cut cell and gene therapy production costs.

Decoding the immune system to pioneer a paradigm shift in disease diagnosis and treatment.

Developing and manufacturing laminin-based cell culture substrates for advanced cell therapies and drug discovery.

Developing precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis.

Combines human immune organoid biology with generative AI to reduce immunogenicity risk in antibody development.